Evaluation of MAGE-1 and MAGE-3 as tumour-specific markers to detect blood dissemination of hepatocellular carcinoma cells. Br J Cancer, 86 (1): 110-... DC Mou,SL Cai,JR Peng,... - Nature Publishing Group 被引量: 307发表: 2002年 Multiple molecular markers MAGE-1, MAGE-3 and \\{AF...
et al. Evaluation of MAGE-1 and MAGE-3 as tumour-specific markers to detect blood dissemination of hepatocellular carcinoma cells. Br J Cancer 86, 110–116 (2002). https://doi.org/10.1038/sj.bjc.6600016 Download citation Received16 July 2001 Revised23 October 2001 Accepted24 October 2001 ...
tumour detection test kitLYOFIA® VEGF for growth factorsfor tumor markersblood tumour detection test kit LYOFIA® VEGF Result display time: 10 min ... angiogenesis,overexpression of VEGF can cause vascular disease. Solidcancerscannot grow beyond a limited size without an ample blood supply. VE...
tumour markers Substances in the blood or urine that indicate, often by abnormal levels, the presence of a malignant tumour in the body. They include proteins such as thyroglobulin and immunoglobulins; glycoproteins such as the prostate-specific antigen (PSI) and CA-125; hormonal peptides such as...
Signed in blood: circulating tumor DNA in cancer diagnosis, treatment and screening. Cancers 13, 3600 (2021). Article CAS Google Scholar Reckamp, K. L. et al. A highly sensitive and quantitative test platform for detection of NSCLC EGFR mutations in urine and plasma. J. Thorac. Oncol. ...
Circulating tumour cells (CTCs) can be captured from a simple blood test and their molecular characterization can provide vital insights into tumour heterogeneity Advances in single-cell genomic profiling have enhanced the ability to interrogate CTCs for 'actionable' aberrations and emerging resistant subc...
Markers of HPV infection and survival in patients with head and neck tumors Int. J. Cancer, 133 (2013), pp. 1832-1839 Google Scholar [22] W. Fuchs, U. Wieland, A. Skaletz-Rorowski, et al. The male ScreenING Study: prevalence of HPV-related genital and anal lesions in an urban coh...
Angiogenic markers, such as αβ integrins and tumour expression of VEGF, have been demonstrated by multiple groups as good PET radiopharmaceuticals [32,33]. After, we describe the main characteristics, advantages and disadvantages of the most important PET radiopharmaceuticals used in tumour functional...
Tumour markers which occur in blood or urine are of value in the management of cancer patients because they allow disease status to be monitored by non-invasive techniques at low cost. An antigen, 'B5', on erythrocytes has been shown to become enhanced when cancer develops, regardless of ...
test;n = 3.j, GCDH gene counts per million (CPM) in HIF-1-overexpressing mouse CD8+T cells. Two-tailed unpairedt-test;n = 332.k, Expression of markers of T cell differentiation and exhaustion in human CD8+T cells after 7–10 days of treatment with or without DEG 500 ...